Skip to main content
NYRADA INC. logo

NYRADA INC. — Investor Relations & Filings

Ticker · NYR ISIN · AU0000070195 ASX Professional, scientific and technical activities
Open in API
Filings indexed 472 across all filing types
Latest filing 2025-11-04 Capital/Financing Update
Country AU Australia
Listing ASX NYR

About NYRADA INC.

https://www.nyrada.com

Nyrada Inc. specializes in the development of novel small molecule therapeutic agents designed to address unmet needs in cardiovascular health and neuroprotection. The company’s lead programs include a cholesterol-lowering treatment and a neuroprotective treatment for brain injury. The cardiovascular program focuses on an oral PCSK9 inhibitor aimed at managing low-density lipoprotein (LDL) cholesterol levels as an alternative to injectable biologics. The neuroprotection program involves the development of NYR-BI03, a first-in-class small molecule designed to mitigate secondary brain damage following a stroke or traumatic brain injury by targeting canonical transient receptor potential (TRPC) ion channels. These efforts aim to provide effective, accessible pharmacological interventions for both chronic metabolic conditions and acute neurological trauma.

Recent filings

Filing Released Lang Actions
Cleansing Statement 3 pages 253.8KB
Capital/Financing Update Classification · 95% confidence The document is a Cleansing Statement issued by Nyrada Inc. regarding the issue of 300,000 CHESS Depositary Interests (CDIs) following options exercised. It references compliance with sections of the Corporations Act 2001 (Cth) and provides legal assurances about disclosure obligations. The document does not contain financial statements, detailed financial performance data, or management discussion of results. It is a regulatory announcement related to capital issuance and compliance rather than a full financial report or earnings release. The document length is 4174 characters, which is relatively short and consistent with a regulatory announcement. The content fits best under Capital/Financing Update (CAP) as it announces a capital issuance event and related compliance statements.
2025-11-04 English
Application for quotation of securities - NYR 6 pages 18.3KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement used to apply for quotation of securities. It details the issuance and quotation of new securities resulting from options being exercised or convertible securities being converted. The document includes specifics such as the number of securities, issue date, issue price, and the resulting issued capital. It is not a financial report, earnings release, or management discussion, but rather a formal announcement related to capital changes and securities quotation on the exchange. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is about 6000 characters, which is consistent with a detailed announcement rather than a brief notice or a full report.
2025-11-02 English
Cleansing Statement 3 pages 245.8KB
Capital/Financing Update Classification · 95% confidence The document is a Cleansing Statement issued by Nyrada Inc. regarding the issue of CHESS Depositary Interests (CDIs) following the exercise of options. It references compliance with sections of the Corporations Act 2001 (Cth) and provides legal assurances about disclosure obligations. The document is relatively short (4174 characters) and primarily serves as a regulatory announcement about a capital issuance event without detailed financial data or report content. It does not contain financial statements, management discussion, or detailed report data. Therefore, it is best classified as a Capital/Financing Update (CAP) since it announces a financing-related event (issuance of securities) and compliance with relevant regulations.
2025-11-02 English
Application for quotation of securities - NYR 6 pages 18.3KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard application for quotation of securities on the ASX (Australian Securities Exchange). It details the issuance and quotation of new securities resulting from options being exercised or convertible securities being converted. The document includes specifics such as the number of securities, issue dates, and classes of securities. This type of filing is related to share issuance and capital changes rather than financial results, management changes, or regulatory announcements. It is not a report or announcement of voting results, nor is it a financial report or earnings release. Therefore, the document fits the category of Share Issue/Capital Change filings.
2025-10-21 English
Cleansing Statement 2 pages 235.2KB
Capital/Financing Update Classification · 95% confidence The document is a Cleansing Statement issued by Nyrada Inc. regarding the issue of CHESS Depositary Interests (CDIs) following options exercised. It references compliance with sections of the Corporations Act 2001 (Cth) and provides legal assurances about disclosure obligations. The document is short (3277 characters) and primarily serves as a regulatory announcement about a capital issuance event without detailed financial data or a full report. It does not contain financial statements or management discussion, nor is it a report publication announcement. The content fits best under Capital/Financing Update (CAP) as it relates to the issuance of securities and compliance notices under capital raising regulations.
2025-10-21 English
Quarterly Activities Report and Appendix 4C 10 pages 559.1KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Nyrada Quarterly Activities Report & Appendix 4C' and covers the three months ending 30 September 2025, indicating it is a quarterly report. It includes detailed clinical program updates, financial and capital updates, cash flow statements, and corporate information. The presence of Appendix 4C, which is a quarterly cash flow report required by ASX Listing Rule 4.7B, confirms this is a regulatory quarterly report. The document contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2025-10-20 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.